Charles Schwab’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180M Sell
1,520,389
-9,074
-0.6% -$1.05M 0.02% 499
2026
Q1
$183M Buy
1,529,463
+45,502
+3% +$5.97M 0.03% 455
2025
Q4
$202M Buy
1,483,961
+19,031
+1% +$2.74M 0.03% 406
2025
Q3
$216M Buy
1,464,930
+11,258
+0.8% +$1.56M 0.03% 389
2025
Q2
$188M Buy
1,453,672
+34,953
+2% +$4.23M 0.03% 412
2025
Q1
$169M Buy
1,418,719
+30,608
+2% +$3.79M 0.03% 436
2024
Q4
$161M Buy
1,388,111
+42,343
+3% +$5.35M 0.03% 449
2024
Q3
$182M Buy
1,345,768
+5,817
+0.4% +$778K 0.03% 401
2024
Q2
$182M Buy
1,339,951
+33,538
+3% +$4.56M 0.03% 414
2024
Q1
$169M Buy
1,306,413
+22,149
+2% +$2.68M 0.04% 401
2023
Q4
$147M Buy
1,284,264
+38,385
+3% +$3.83M 0.04% 412
2023
Q3
$113M Buy
1,245,879
+18,696
+2% +$1.93M 0.03% 453
2023
Q2
$138M Buy
1,227,183
+293,333
+31% +$31M 0.04% 398
2023
Q1
$97.8M Buy
933,850
+5,069
+0.5% +$529K 0.03% 509
2022
Q4
$103M Buy
928,781
+21,909
+2% +$2.3M 0.03% 470
2022
Q3
$79.2M Buy
906,872
+29,292
+3% +$2.66M 0.03% 527
2022
Q2
$68.6M Buy
877,580
+8,965
+1% +$740K 0.02% 597
2022
Q1
$74.1M Buy
868,615
+27,412
+3% +$2.63M 0.02% 648
2021
Q4
$101M Buy
841,203
+24,453
+3% +$3.03M 0.03% 525
2021
Q3
$101M Buy
816,750
+6,969
+0.9% +$897K 0.03% 479
2021
Q2
$97.1M Buy
809,781
+14,874
+2% +$1.7M 0.03% 508
2021
Q1
$83.6M Buy
794,907
+19,632
+3% +$1.99M 0.03% 543
2020
Q4
$78.9M Buy
775,275
+7,610
+1% +$715K 0.03% 525
2020
Q3
$64.6M Sell
767,665
-58,417
-7% -$4.55M 0.03% 520
2020
Q2
$53.7M Buy
826,082
+8,220
+1% +$543K 0.03% 588
2020
Q1
$53.3M Buy
817,862
+11,091
+1% +$874K 0.03% 500
2019
Q4
$63.6M Buy
806,771
+12,911
+2% +$1M 0.03% 504
2019
Q3
$63.2M Sell
793,860
-325,555
-29% -$25.6M 0.04% 467
2019
Q2
$93.6M Buy
1,119,415
+31,957
+3% +$2.55M 0.06% 323
2019
Q1
$86M Buy
1,087,458
+62,889
+6% +$4.59M 0.06% 328
2018
Q4
$68.4M Buy
1,024,569
+28,207
+3% +$1.95M 0.05% 340
2018
Q3
$79.6M Buy
996,362
+69,230
+7% +$5.17M 0.05% 330
2018
Q2
$62.5M Buy
927,132
+34,644
+4% +$2.52M 0.05% 402
2018
Q1
$68.7M Buy
892,488
+31,980
+4% +$2.36M 0.05% 341
2017
Q4
$58.7M Buy
860,508
+27,119
+3% +$1.8M 0.05% 384
2017
Q3
$52.2M Buy
833,389
+48,246
+6% +$2.88M 0.05% 395
2017
Q2
$43.5M Buy
785,143
+34,064
+5% +$1.77M 0.04% 451
2017
Q1
$37.7M Buy
751,079
+32,508
+5% +$1.58M 0.04% 478
2016
Q4
$35.6M Buy
718,571
+11,799
+2% +$598K 0.04% 457
2016
Q3
$37.1M Buy
706,772
+25,351
+4% +$1.24M 0.04% 416
2016
Q2
$30.4M Buy
681,421
+24,569
+4% +$1.07M 0.04% 476
2016
Q1
$26.9M Buy
656,852
+49,370
+8% +$1.82M 0.04% 498
2015
Q4
$22.2M Buy
607,482
+23,843
+4% +$862K 0.03% 560
2015
Q3
$19.2M Buy
583,639
+16,367
+3% +$551K 0.03% 568
2015
Q2
$21M Buy
567,272
+22,484
+4% +$818K 0.03% 549
2015
Q1
$19.1M Buy
544,788
+27,534
+5% +$971K 0.03% 587
2014
Q4
$19.7M Buy
517,254
+19,945
+4% +$730K 0.03% 523
2014
Q3
$17.6M Buy
497,309
+7,995
+2% +$297K 0.03% 535
2014
Q2
$19.1M Buy
489,314
+11,191
+2% +$418K 0.03% 500
2014
Q1
$17.4M Buy
478,123
+23,449
+5% +$855K 0.03% 510
2013
Q4
$15.7M Buy
454,674
+44,201
+11% +$1.42M 0.03% 508
2013
Q3
$11.6M Buy
410,473
+18,125
+5% +$483K 0.02% 568
2013
Q2
$10.8M Buy
+392,348
New +$10.8M 0.02% 543

Other funds holding XYL

Charles Schwab's XYL Position: Q2 2026 in Review

Charles Schwab reduced its Xylem (XYL) stake by 0.59% in Q2 2026, selling an estimated $1.05M and leaving 1,520,389 shares worth $180M. The position accounts for 0.02% of the portfolio, ranked #499.

Charles Schwab first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $216M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Charles Schwab held 1,520,389 shares of Xylem worth $180M as of Q2 2026.
  • Charles Schwab sold 9,074 Xylem shares in Q2 2026, an estimated $1.05M.
  • Xylem made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #499 holding.
  • Charles Schwab first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Xylem position peaked at $216M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.